CRBP icon

Corbus Pharmaceuticals
CRBP

Overview Fund Activity

99 hedge funds and large institutions have $129M invested in Corbus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 26 closing their positions.

Holders
99
Holders Change
-8
Holders Change %
-7.48%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
34
Reduced
22
Closed
26
Calls
$6.57M
Puts
$776K
Net Calls
+$5.8M
Net Calls Change
+$1.77M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$4.56M
2
O
2
OrbiMed
New York
$13.8M
3
AC
3
Armistice Capital
New York
$2.78M
4
ACM
4
Altium Capital Management
New York
$4.54M
5
PM
5
Prosight Management
Texas
$3.19M

Top Sellers

1
Assenagon Asset Management
1
Assenagon Asset Management
Luxembourg
$0
2
State Street
2
State Street
Massachusetts
$2.7M
3
TCM
3
Tang Capital Management
California
$2.86M
4
SSA
4
Schonfeld Strategic Advisors
New York
$0
5
IC
5
Ikarian Capital
Texas
$607K
Name Market Value Shares Shares
Change 		Shares
Change %
CAM
1
Cormorant Asset Management
Massachusetts
$28M 2,375,000 – –
O
2
OrbiMed
New York
$13.8M 1,172,287 +259,735 +28%
OCA
3
Octagon Capital Advisors
New York
$13.2M 1,115,000 – –
BlackRock
4
BlackRock
New York
$10.3M 873,374 +70,653 +9%
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.78M 659,202 +13,552 +2%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$6.24M 528,937 – –
Millennium Management
7
Millennium Management
New York
$4.56M 386,653 +283,902 +276%
ACM
8
Altium Capital Management
New York
$4.54M 385,000 +190,000 +97%
PM
9
Prosight Management
Texas
$3.19M 270,000 +140,000 +108%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$3.11M 263,532 +13,773 +6%
TCM
11
Tang Capital Management
California
$2.86M 242,653 -357,347 -60%
AC
12
Armistice Capital
New York
$2.78M 236,000 +236,000 New
State Street
13
State Street
Massachusetts
$2.7M 228,600 -366,976 -62%
VC
14
Vivo Capital
California
$1.97M 166,794 – –
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$1.95M 164,735 -160,933 -49%
Mirae Asset Global ETFs Holdings
16
Mirae Asset Global ETFs Holdings
Hong Kong
$1.92M 162,962 -9,668 -6%
Renaissance Technologies
17
Renaissance Technologies
New York
$1.64M 139,100 +123,100 +769%
Two Sigma Investments
18
Two Sigma Investments
New York
$1.58M 134,175 +91,205 +212%
Northern Trust
19
Northern Trust
Illinois
$1.22M 103,264 +11,400 +12%
HP
20
HealthInvest Partners
Sweden
$1.19M 98,304 +28,731 +41%
Charles Schwab
21
Charles Schwab
California
$1.16M 97,882 +4,239 +5%
UBS Group
22
UBS Group
Switzerland
$1.05M 89,377 +65,162 +269%
HS
23
HighVista Strategies
Massachusetts
$888K 75,292 – –
Morgan Stanley
24
Morgan Stanley
New York
$727K 61,631 -93,115 -60%
Goldman Sachs
25
Goldman Sachs
New York
$675K 57,174 +7,754 +16%
1
2 3 4 5